Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Prospective, Non-intervention, Observational Study to Evaluate the Effectiveness and Safety of the Rozetel Tablet in Patients Who Had Undergone Percutaneous Coronary Intervention(PCI)

NCT07084246 is registered in ClinicalTrials.gov with GC Biopharma Corp as lead sponsor.

NCT NCT07084246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07084246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Prospective, Non-intervention, Observational Study to Evaluate the Effectiveness and Safety of the Rozetel Tablet in Patients Who Had Undergone Percutaneous Coronary Intervention(PCI)
Lead sponsor
GC Biopharma Corp
Phase
Observational
Overall status
Active, not recruiting
Start date
June 7, 2023
Completion date
December 31, 2025
Enrollment
1,563 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, dyslipidemia